Now we have some live contracts with world famous manufacturers and presenting their products on the Ukrainian market with very good results.
Our company interested in the developing own trademarks for portfolio extension. We kindly invite to cooperation manufacturers of pharmaceutical products and would be happy to thank you for letter with proposal.
BaDM is an exclusive importer of Jericho cosmetics in Ukraine.
Paloma Dead Sea Ltd has been dealing with manufacturing of cosmetics for the fourth decade and is the first company in the modern world that started development and output of the cosmetic and therapeutic products based on the salts, minerals and black muds from the Dead Sea.
Valeant now will be called Bausch Health, CNBC reported. New brand will become valid starting from July 2018, said Joseph Papa, CEO. He noted that he had been thinking about renaming since the very moment when he started managing Valeant in 2016, as the company under his management is more than just a producer of drugs
Portalak appeared recently in the pharmacies of Ukraine, in June 2015. Although in Europe this drug has existed for a quarter of a century. Lactulose that is found in Portalac has a high degree of purification.
There are two pieces of news for the pharmacists - one bad and one good: the bad one is that the moratorium for inspections of pharmacies is abolished and the good one is that there is a time to get ready for inspections
The stocks of US pharm distributors have risen after a report informing that the world biggest online retailer Amazon abandons its plans to sell prescription drugs to hospitals and clinics according to the reports from Reuters and CNBC
Buy 20 packs. Betadin in the range - get a 5% discount, 50 pack. - 7%, 100 packs. - 10%!
The action is held throughout the territory of Ukraine, except for the zone of carrying out ATO and temporarily occupied territories.
Promotion 3 + 1! IMOSTAT- Prevention and treatment of influenza A and B, acute respiratory viral infections, including complicated. As part of complex therapy of chronic bronchitis, pneumonia and recurrent herpetic infection.
Remedium with reference to FierceBiotech informs that on the findings of the clinical research studies, the new trial three-in-one inhaler from AstraZeneca has outperformed in terms of efficiency Symbicort and other two-drug inhalers.